CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Translational Neurodegeneration

journal

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 3, 2026
Entity authorityQ18216027 ↗
Source-derived summary

Translational Neurodegeneration is a peer-reviewed, medical journal covering the field of neurodegenerative diseases, such as Parkinson's and Alzheimer's disease. It was established in 2012 and is published by BioMed Central. The editor-in-chief is Shengdi Chen (School of Medicine, Shanghai Jiao Tong University).

Abstracting and indexing

The journal is abstracted and indexed in Chemical Abstracts Service and Scopus.

Editorial summary

Begin with the source’s own compact description: “Translational Neurodegeneration” is journal. The dossier treats that line as a proposition to test through Translational, Neurodegeneration and journal, not as a finished interpretation.

Editorial reviewA concise reference frame for defining the subject, testing terminology and identifying the institution closest to the evidence. The current lead gives the account dated anchors—2012—that can be checked directly. The linked authority record independently contributes the date 2012-01-01. For this dossier, Translational, Neurodegeneration and journal is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “journal” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 3, 2026. The linked authority identifier is Q18216027. 3 of 3 selected statements include explicit references; 1 carry qualifiers and 0 use preferred rank. The first chronological checks are 2012.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Translational Neurodegeneration”, its source revision and the description used here.
  2. Expand the search: follow Translational Neurodegeneration primary sources, Translational Neurodegeneration archive and Translational research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Translational Neurodegeneration”?
  2. What terminology or title could unlock a more precise catalogue search?
  3. Which cited source is closest to the event, object or claim?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Translational Neurodegeneration” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.